CI Stock Recent News

Cigna's unit Evernorth Health said on Wednesday it will take several steps to help lower out-of-pocket cost of prescription drugs for patients at its pharmacy stores.

Actions aim to lower patient out-of-pocket costs Expands transparency for both patients and those who provide their benefits BLOOMFIELD, Conn. , Jan. 29, 2025 /PRNewswire/ -- Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), today announced several steps it is taking to improve costs and transparency around pharmacy benefits.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Tyson Foods, Cigna Group, Eldorado Gold, ChampionX and Akamai Technologies.

The Q4 earnings season continued on a positive note after big banks and other financials struck a bullish tone in the first two weeks of reporting. Highly anticipated reports from the Magnificent 7 will be in focus over the next couple of weeks. Southwest Airlines is set to report their Q4 2024 results on Thursday, January 30, a week later than expected.

CI's fourth-quarter results are likely to have benefited from growing premiums and pharmacy revenues.

Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and consistent earnings growth, with Healthcare and Evernorth divisions driving strong performance and a 13% EPS CAGR over 10 years. Management targets 10-14% long-term annual EPS growth, supported by increased biosimilar adoption, behavioral health services growth, and aggressive share buybacks.

Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.

The report comes at a time when insurers are grappling with rising medical costs.

BLOOMFIELD, Conn. , Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day.

BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers.